LivaNova (LIVN)
LivaNova on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as electromedical & electrotherapeutic apparatus.
6.0M
Short interest
settlement 2026-09-30
8.0
Days to cover
-1.6 days vs prior
74.7%
Short share of volume
2026-10-09
709
Fails to deliver
settlement 2026-09-14
Wed 4 Nov
Next earnings
estimated date
-$800K
Insider flow, 90 days
0 buys, 4 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in LIVN is 6,003,050 shares, up 1,015,293 shares over the last month. Over the last 48 readings it ranged from 1,554,231 shares (14 March 2025) to 6,003,050 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 747K shares a day that is 8.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/livn" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 6,003,050 | +11.7% | 747,064 | 8.04 |
| 2026-09-15 | 5,375,448 | +7.8% | 555,905 | 9.67 |
| 2026-08-31 | 4,987,757 | +5.6% | 556,765 | 8.96 |
| 2026-08-14 | 4,721,380 | +13.9% | 869,418 | 5.43 |
| 2026-07-31 | 4,143,484 | +1.4% | 523,922 | 7.91 |
| 2026-07-15 | 4,086,510 | +3.7% | 570,743 | 7.16 |
| 2026-06-30 | 3,939,424 | +13.9% | 932,933 | 4.22 |
| 2026-06-15 | 3,457,706 | +3.5% | 751,504 | 4.60 |
| 2026-05-29 | 3,340,286 | -0.2% | 660,337 | 5.06 |
| 2026-05-15 | 3,345,840 | -1.1% | 1,022,138 | 3.27 |
| 2026-04-30 | 3,381,707 | +5.9% | 713,757 | 4.74 |
| 2026-04-15 | 3,194,655 | +7.1% | 719,305 | 4.44 |
| 2026-03-31 | 2,983,194 | +7.1% | 803,880 | 3.71 |
| 2026-03-13 | 2,785,113 | +16.1% | 962,209 | 2.89 |
| 2026-02-27 | 2,399,324 | +18.0% | 1,006,390 | 2.38 |
| 2026-02-13 | 2,032,704 | -16.6% | 676,965 | 3.00 |
| 2026-01-30 | 2,436,767 | +32.7% | 603,535 | 4.04 |
| 2026-01-15 | 1,836,041 | -9.6% | 560,744 | 3.27 |
| 2025-12-31 | 2,031,503 | -5.4% | 501,686 | 4.05 |
| 2025-12-15 | 2,147,024 | -6.3% | 616,541 | 3.48 |
| 2025-11-28 | 2,292,265 | +8.2% | 570,625 | 4.02 |
| 2025-11-14 | 2,118,723 | +16.0% | 773,977 | 2.74 |
| 2025-10-31 | 1,826,898 | -5.6% | 450,643 | 4.05 |
| 2025-10-15 | 1,935,954 | -6.2% | 404,306 | 4.79 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of LIVN volume is 74.7%, up 14.4 points over the last five sessions. Over the last 30 readings it ranged from 33.0% (30 September 2026) to 83.8% (14 September 2026). The latest reading is 9.2 points above the 30-session average of 65.5%, on 120K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 90K | 120K | 74.7% | 0 |
| 2026-10-08 | 123K | 171K | 72.1% | 368 |
| 2026-10-07 | 246K | 340K | 72.5% | 466 |
| 2026-10-06 | 93K | 136K | 68.4% | 0 |
| 2026-10-05 | 96K | 168K | 57.0% | 118 |
| 2026-10-02 | 109K | 181K | 60.3% | 0 |
| 2026-10-01 | 132K | 323K | 40.9% | 0 |
| 2026-09-30 | 146K | 442K | 33.0% | 0 |
| 2026-09-29 | 132K | 226K | 58.4% | 0 |
| 2026-09-28 | 137K | 230K | 59.4% | 0 |
| 2026-09-25 | 204K | 295K | 69.2% | 0 |
| 2026-09-24 | 218K | 491K | 44.5% | 0 |
| 2026-09-23 | 108K | 184K | 58.9% | 0 |
| 2026-09-22 | 154K | 261K | 59.2% | 1,381 |
| 2026-09-21 | 160K | 219K | 73.3% | 0 |
| 2026-09-18 | 139K | 219K | 63.7% | 0 |
| 2026-09-17 | 111K | 205K | 54.4% | 0 |
| 2026-09-16 | 118K | 294K | 40.0% | 0 |
| 2026-09-15 | 175K | 233K | 75.4% | 0 |
| 2026-09-14 | 194K | 231K | 83.8% | 0 |
| 2026-09-11 | 174K | 225K | 77.4% | 313 |
| 2026-09-10 | 115K | 149K | 77.4% | 0 |
| 2026-09-09 | 168K | 232K | 72.4% | 0 |
| 2026-09-08 | 114K | 150K | 76.1% | 0 |
| 2026-09-04 | 82K | 110K | 74.2% | 5 |
| 2026-09-03 | 182K | 257K | 71.0% | 4,741 |
| 2026-09-02 | 212K | 279K | 76.1% | 0 |
| 2026-09-01 | 147K | 209K | 70.2% | 102 |
| 2026-08-31 | 152K | 195K | 77.9% | 0 |
| 2026-08-28 | 122K | 170K | 72.0% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 September 2026, the fails-to-deliver balance in LIVN is 709 shares, up 692 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (11 May 2026) to 65,403 shares (29 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-14 | 709 | $78.18 | $55K |
| 2026-08-21 | 17 | $78.21 | $1K |
| 2026-08-12 | 84 | $78.58 | $7K |
| 2026-08-04 | 175 | $82.46 | $14K |
| 2026-08-03 | 105 | $80.14 | $8K |
| 2026-07-31 | 4,511 | $81.05 | $366K |
| 2026-07-27 | 5,622 | $78.19 | $440K |
| 2026-07-20 | 70 | $80.70 | $6K |
| 2026-07-14 | 14,260 | $82.98 | $1.2M |
| 2026-07-13 | 34 | $82.56 | $3K |
| 2026-07-09 | 15 | $82.51 | $1K |
| 2026-07-02 | 721 | $82.48 | $59K |
| 2026-06-30 | 39,003 | $83.06 | $3.2M |
| 2026-06-29 | 65,403 | $83.43 | $5.5M |
| 2026-06-25 | 113 | $79.95 | $9K |
| 2026-06-22 | 4 | $78.50 | $314 |
| 2026-06-15 | 24,998 | $79.39 | $2.0M |
| 2026-06-12 | 24,999 | $79.94 | $2.0M |
| 2026-06-05 | 1,941 | $73.72 | $143K |
| 2026-06-03 | 950 | $73.33 | $70K |
| 2026-05-28 | 60,890 | $73.90 | $4.5M |
| 2026-05-27 | 66 | $75.42 | $5K |
| 2026-05-21 | 7 | $73.71 | $516 |
| 2026-05-13 | 19,305 | $71.75 | $1.4M |
| 2026-05-11 | 1 | $71.86 | $72 |
| 2026-05-06 | 18,361 | $57.59 | $1.1M |
| 2026-05-04 | 8 | $61.00 | $488 |
| 2026-04-28 | 3,638 | $63.41 | $231K |
| 2026-04-23 | 27 | $65.18 | $2K |
| 2026-04-15 | 10 | $64.99 | $650 |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at LIVN reported 4 open-market sells worth $800K in the last 90 days and no open-market buys. Latest filing: Bianchi Francesco (Director) on 2026-09-10.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | Bianchi Francesco | Director | Sell | 4K | $78.01 | $273K | 4K |
| 2026-09-04 | Story Brooke | Director | Sell | 2K | $81.42 | $187K | 7K |
| 2026-08-31 | Bianchi Francesco | Director | Sell | 2K | $79.72 | $132K | 8K |
| 2026-08-11 | Tezel Ahmet | Chief Innovation Officer | Sell | 3K | $77.74 | $208K | 6K |
| 2026-08-11 | Tezel Ahmet | Chief Innovation Officer | Tax withholding | 1K | $77.86 | $111K | 9K |
| 2026-08-11 | Tezel Ahmet | Chief Innovation Officer | Disposition | 9K | $77.86 | $669K | 10K |
| 2026-08-11 | Tezel Ahmet | Chief Innovation Officer | Option exercise | 13K | $52.68 | $669K | 19K |
| 2026-06-15 | Zurbay Donald | Director | Option exercise | 3K | $0.00 | $0 | 3K |
| 2026-06-15 | Zurbay Donald | Director | Tax withholding | 308 | $79.70 | $25K | 2K |
| 2026-06-15 | Story Brooke | Director | Option exercise | 4K | $0.00 | $0 | 10K |
| 2026-06-15 | Story Brooke | Director | Tax withholding | 486 | $79.70 | $39K | 10K |
| 2026-06-15 | Enxing Seng Stacy | Director | Option exercise | 4K | $0.00 | $0 | 16K |
| 2026-06-15 | Enxing Seng Stacy | Director | Tax withholding | 486 | $79.70 | $39K | 15K |
| 2026-06-15 | KOZY WILLIAM A | Director | Option exercise | 6K | $0.00 | $0 | 38K |
| 2026-06-15 | KOZY WILLIAM A | Director | Tax withholding | 682 | $79.70 | $54K | 38K |
| 2026-06-15 | Tezel Ahmet | Chief Innovation Officer | Tax withholding | 1K | $79.70 | $82K | 6K |
| 2026-06-15 | Tezel Ahmet | Chief Innovation Officer | Option exercise | 3K | $0.00 | $0 | 7K |
| 2026-06-15 | Barry James Christopher | Director | Option exercise | 4K | $0.00 | $0 | 8K |
| 2026-06-15 | Barry James Christopher | Director | Tax withholding | 486 | $79.70 | $39K | 8K |
| 2026-06-15 | PODLOGAR SUSAN M | Director | Option exercise | 4K | $0.00 | $0 | 6K |
| 2026-06-15 | PODLOGAR SUSAN M | Director | Tax withholding | 486 | $79.70 | $39K | 6K |
| 2026-06-15 | Bianchi Francesco | Director | Sell | 1K | $80.19 | $96K | 10K |
| 2026-06-15 | Bianchi Francesco | Director | Option exercise | 4K | $0.00 | $0 | 11K |
| 2026-06-15 | Bianchi Francesco | Director | Tax withholding | 486 | $79.70 | $39K | 11K |
| 2026-06-15 | SCHERMERHORN TODD C | Director | Option exercise | 4K | $0.00 | $0 | 13K |
| 2026-06-15 | SCHERMERHORN TODD C | Director | Tax withholding | 486 | $79.70 | $39K | 13K |
| 2026-06-15 | WILVER PETER M | Director | Option exercise | 4K | $0.00 | $0 | 11K |
| 2026-06-15 | WILVER PETER M | Director | Tax withholding | 486 | $79.70 | $39K | 10K |
| 2026-05-26 | Bianchi Francesco | Director | Sell | 2K | $75.75 | $136K | 7K |
| 2026-03-30 | Tezel Ahmet | Chief Innovation Officer | Tax withholding | 1K | $61.27 | $73K | 4K |
| 2026-03-30 | Tezel Ahmet | Chief Innovation Officer | Option exercise | 3K | $0.00 | $0 | 5K |
| 2026-03-30 | Poletti Franco | President, Cardiopulmonary | Tax withholding | 1K | $61.27 | $84K | 11K |
| 2026-03-30 | Poletti Franco | President, Cardiopulmonary | Option exercise | 3K | $0.00 | $0 | 12K |
| 2026-03-30 | Shvartsburg Alex | Chief Financial Officer | Tax withholding | 13K | $61.27 | $788K | 45K |
| 2026-03-30 | Shvartsburg Alex | Chief Financial Officer | Option exercise | 31K | $0.00 | $0 | 58K |
| 2026-03-30 | Makatsaria Vladimir | Chief Executive Officer | Tax withholding | 11K | $61.27 | $684K | 14K |
| 2026-03-30 | Makatsaria Vladimir | Chief Executive Officer | Option exercise | 21K | $0.00 | $0 | 25K |
| 2026-03-30 | Kozmina Natalia | Chief Human Resources Officer | Tax withholding | 1K | $61.27 | $84K | 5K |
| 2026-03-30 | Kozmina Natalia | Chief Human Resources Officer | Option exercise | 6K | $0.00 | $0 | 6K |
| 2026-03-30 | Bolton Stephanie | President, Global Epilepsy | Tax withholding | 8K | $61.27 | $513K | 22K |
| 2026-03-30 | Bolton Stephanie | President, Global Epilepsy | Option exercise | 18K | $0.00 | $0 | 31K |
| 2026-03-11 | Poletti Franco | President, Cardiopulmonary | Tax withholding | 69 | $62.26 | $4K | 9K |
| 2026-03-11 | Poletti Franco | President, Cardiopulmonary | Tax withholding | 2K | $62.26 | $123K | 9K |
| 2026-03-11 | Poletti Franco | President, Cardiopulmonary | Option exercise | 2K | $57.60 | $123K | 11K |
| 2025-12-15 | Poletti Franco | President, Cardiopulmonary | Tax withholding | 416 | $63.06 | $26K | 9K |
| 2025-12-15 | Poletti Franco | President, Cardiopulmonary | Option exercise | 967 | $0.00 | $0 | 9K |
| 2025-12-15 | PODLOGAR SUSAN M | Director | Tax withholding | 269 | $63.06 | $17K | 2K |
| 2025-12-15 | PODLOGAR SUSAN M | Director | Option exercise | 2K | $0.00 | $0 | 2K |
| 2025-12-15 | Hutchinson Michael Damon | SVP, CLO and Company Secretary | Tax withholding | 1K | $63.06 | $71K | 7K |
| 2025-12-15 | Hutchinson Michael Damon | SVP, CLO and Company Secretary | Option exercise | 2K | $0.00 | $0 | 8K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON8 Form 144 notices on file for LIVN worth $1.9M at the prices reported; 5 in the last 90 days worth $1.7M. Latest: Bianchi Francesco filed on 2026-09-10 to sell 3,500 shares ($273K) from 2026-09-10.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-10 | Bianchi FrancescoOfficer | 4K | $273K | 0.006% | 2026-09-10 | Merrill Lynch |
| 2026-09-04 | Story BrookeOfficer | 2K | $187K | 0.004% | 2026-09-04 | Merrill Lynch |
| 2026-09-02 | Poletti FrancoOfficer | 11K | $883K | 0.020% | 2026-09-02 | Merrill Lynch |
| 2026-08-31 | Bianchi FrancescoOfficer | 2K | $132K | 0.003% | 2026-08-31 | Merrill Lynch |
| 2026-08-11 | Tezel AhmetOfficer | 3K | $210K | 0.005% | 2026-08-11 | Merrill Lynch |
| 2026-06-15 | Bianchi FrancescoOfficer | 1K | $96K | 0.002% | 2026-06-15 | Merrill Lynch |
| 2026-05-26 | Bianchi FrancescoOfficer | 2K | $136K | 0.003% | 2026-05-26 | Merrill Lynch |
| 2025-11-18 | Story BrookeDirector | 250 | $13K | 0.000% | 2025-11-18 | Merrill Lynch |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON3 holders report 5% or more of LIVN in their latest filing, all on Schedule 13G (passive). The largest reported stake is PRIMECAP MANAGEMENT CO/CA/ at 7.7% of the class (4,224,852 shares), filed 2026-02-12 for an event on 2025-12-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-06 | 13G | FMR LLCparent holding company | 3.2M | 5.8% | 2026-06-30 |
| 2026-08-06 | 13G | Abigail P. Johnsonindividual | 3.2M | 5.8% | 2026-06-30 |
| 2026-04-30 | 13G/Ano. 4 | Millennium Management LLCother entity | 2.4M | 4.4% | 2026-03-31 |
| 2026-04-30 | 13G/Ano. 4 | Millennium Group Management LLCother entity | 2.4M | 4.4% | 2026-03-31 |
| 2026-04-30 | 13G/Ano. 4 | Israel A. Englanderindividual | 2.4M | 4.4% | 2026-03-31 |
| 2026-04-30 | 13G/Ano. 4 | Integrated Core Strategies (US) LLCother entity | 2.3M | 4.2% | 2026-03-31 |
| 2026-02-12 | 13G/Ano. 8 | PRIMECAP MANAGEMENT CO/CA/investment adviser | 4.2M | 7.7% | 2025-12-31 |
13F holders
Tracked managers holding LIVN at their latest 13F. JSON4 of the 30 tracked managers held LIVN at their latest 13F, $243.1M in total at quarter-end prices. AQR Capital Management is the largest at $191.0M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 0 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 2.4M | $191.0M | 0.07% | -138K |
| Millennium Management | 2026-06-30 | 502K | $41.3M | 0.01% | -1.9M |
| Renaissance Technologies | 2026-06-30 | 113K | $9.3M | 0.01% | -70K |
| Two Sigma Investments | 2026-06-30 | 18K | $1.5M | 0.00% | -30K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) LivaNova reported revenue of $390.6M, up 10.8% from the same quarter a year earlier, and net income of $108.6M (1.93 diluted EPS). In FY 2025 it generated $254.3M of operating cash flow. As of 2026-06-30, cash was $516.6M against $290.1M of debt.
- Cash
- $516.6M
- Debt
- $290.1M
- Equity
- $1.33B
- Total assets
- $2.64B
- Shares outstanding
- 55,093,507
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $390.6M | $108.6M | 27.8% | 1.93 |
| Q1 FY 2026 | 2026-03-31 | $362.3M | $22.3M | 6.2% | 0.40 |
| Q4 FY 2025derived | 2025-12-31 | $360.9M | $30.9M | 8.6% | n/a |
| Q3 FY 2025 | 2025-09-30 | $357.8M | $26.8M | 7.5% | 0.49 |
| Q2 FY 2025 | 2025-06-30 | $352.5M | $27.2M | 7.7% | 0.50 |
| Q1 FY 2025 | 2025-03-31 | $316.9M | -$327.3M | -103.3% | -6.01 |
| Q4 FY 2024derived | 2024-12-31 | $321.8M | $55.9M | 17.4% | n/a |
| Q3 FY 2024 | 2024-09-30 | $318.1M | $33.0M | 10.4% | 0.60 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1.39B | -$242.5M | $254.3M | $81.0M | n/a | n/a |
| FY 2024 | 2024-12-31 | $1.25B | $63.2M | $183.0M | $47.1M | n/a | n/a |
| FY 2023 | 2023-12-31 | $1.15B | $17.5M | $74.9M | $35.0M | n/a | n/a |
| FY 2022 | 2022-12-31 | $1.02B | -$86.2M | $69.9M | $26.5M | n/a | n/a |
| FY 2021 | 2021-12-31 | $1.04B | -$135.8M | $102.5M | $25.5M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-29 from the cover page.
What this page is
LivaNova in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows LivaNova (LIVN), SEC CIK 1639691, listed on Nasdaq, classified by the SEC as electromedical & electrotherapeutic apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-10.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-06.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-10.JSON and CSV
- Company record
- EDGAR filing index for CIK 1639691Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as electromedical & electrotherapeutic apparatus
Other company pages
Datasets
Frequently Asked Questions
How much of LIVN is sold short?
What is LIVN's daily short volume?
Does LIVN have fails to deliver?
Are LIVN insiders buying or selling?
Have LIVN insiders filed to sell?
Who owns 5% or more of LIVN?
What did LIVN report last quarter?
Which tracked 13F managers own LIVN?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.